GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
228 hedge funds and large institutions have $2.14B invested in Genomic Health, Inc. in 2018 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less call options, than puts
Call options by funds: $2.97M | Put options by funds: $4.21M
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
228
Holding in Top 10
1
Calls
$2.97M
Puts
$4.21M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$18.6M | |
| 3 | +$16.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.2M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$13.9M |
Top Sellers
| 1 | -$132M | |
| 2 | -$19.7M | |
| 3 | -$9.76M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$7.06M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.03M |